Press Release | NeoGenomics Laboratories

November 7, 2022

NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors

October 28, 2022

NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch

October 13, 2022

NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022

October 3, 2022

NeoGenomics Lab Operations | Hurricane Ian Update

September 29, 2022

NeoGenomics Hurricane Ian Emergency Response

September 7, 2022

NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022

August 16, 2022

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 9, 2022

NeoGenomics Reports Revenue of $125 Million in the Second Quarter

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients